Hu Zhou
State Key Laboratory Of Drug Research
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Phase separation-based HTS identifies cobimetinib as a YAP-TEAD inhibitor that suppresses hyperactivated YAP-induced cancer progression.
Journal: Science translational medicine
Published: April 22, 2026
ASB7 is a negative regulator of H3K9me3 homeostasis.
Journal: Science (New York, N.Y.)
Published: May 29, 2025
Sertraline and Astemizole Enhance the Deubiquitinase Activity of USP7 by Binding to Its Switching Loop Region.
Journal: Journal of medicinal chemistry
Published: February 25, 2025
Advancements in proteogenomics for preclinical targeted cancer therapy research.
Journal: Biophysics reports
Published: October 23, 2024
Benzbromarone interferes with the interaction between Hsp90 and Aha1 by interacting with both of them.
Journal: Communications biology
Published: May 15, 2024
Uncovering PROTAC Sensitivity and Efficacy by Multidimensional Proteome Profiling: A Case for STAT3.
Uncovering PROTAC Sensitivity and Efficacy by Multidimensional Proteome Profiling: A Case for STAT3.
Journal: Journal of medicinal chemistry
Published: March 11, 2024
A novel capsid-XL32-derived adeno-associated virus serotype prompts retinal tropism and ameliorates choroidal neovascularization.
Journal: Biomaterials
Published: June 19, 2023
Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies.
Journal: Cell
Published: December 19, 2022
Conjugation site characterization of antibody-drug conjugates using electron-transfer/higher-energy collision dissociation (EThcD).
Journal: Analytica chimica acta
Published: November 30, 2022
Selective activator of human ClpP triggers cell cycle arrest to inhibit lung squamous cell carcinoma.
Journal: Nature communications
Published: November 23, 2022
Last Updated: 09/26/2026